ROCKVILLE, Md., March 16, 2018 -- Dinocrates Group LLC, a boutique strategy and technology advisory firm, announced today that it has been awarded a five-year contract to provide federal, state and local government agencies with business consulting solutions through the General Services Administration (GSA) Professional Services Schedule (PSS).
Dinocrates will provide business consulting solutions under PSS’ Integrated Business Program Support Services (874-7). PSS gives federal agencies a streamlined procurement procedure to access carefully vetted and proven vendors through a single contract. Business consulting solutions range from consulting, facilitation, quality assurance, analysis, strategy formulation, advisory and assistance, research, and training to acquisition and program support.
“We are extremely pleased to now offer a fast, convenient way for government agencies to procure our proven management and consulting services and solutions,” said Tom Prokop, President and CEO of Dinocrates. “We look forward to providing expanded services for our existing customers and developing relationships with new ones, all with the goal of helping federal, state and local agencies improve their performance and meet their mission goals.”
The PSS award marks the second GSA contract award for Dinocrates, which received a GSA IT Schedule 70 award in June 2017. Agencies interested in working with Dinocrates can contact the firm directly at (240) 403-4103 or at [email protected].
About Dinocrates Group
Dinocrates is a boutique strategy and technology advisory firm headquartered in Rockville, MD. It partners with clients from the public and private sectors to identify their highest-value opportunities, address their most critical challenges, and transform their enterprises. For more information on Dinocrates and its services, visit www.dinocratesgroup.com.
Contact: Ivy Eckerman Spire Communications for Dinocrates Group LLC (540) 373-2963 [email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



